>
pdufa.bio

RGX-314

Updated ยทnext FDA decision on the calendar

RGX-314 is a REGENXBIO Inc. program. Its next catalyst is a Readout in Q4 2026. Every date links its source.

RGNX catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: REGENXBIO Inc. (RGNX). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Q4 2026RGNX

Questions

When is RGX-314's next FDA decision or readout?

The next tracked catalyst for RGX-314 is a Readout in Q4 2026.

What happened at RGX-314's most recent FDA decision?

No FDA decision for RGX-314 is in our archive yet.

Who makes RGX-314?

REGENXBIO Inc. (RGNX).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.